⚡️Launch official Telegram Ads with Telega.io
Fully managed campaigns across 10+ GEOs — setup, targeting, and reports on us
![Telegram Channel logo [𝗢𝗡𝗟𝗜𝗡𝗘 𝗣𝗛𝗔𝗥𝗠𝗔™]. Free Telegram Channel Analytics](https://storage.yandexcloud.net/telega.stat.channels/75cbi7i25jpk5u7z98owmj0fog8k?response-content-disposition=inline%3B%20filename%3D%22avatar-752894.jpg%22%3B%20filename%2A%3DUTF-8%27%27avatar-752894.jpg&response-content-type=image%2Fjpeg&x-amz-checksum-mode=ENABLED&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=YCAJELyQpmJomwE4udALJdNHw%2F20260519%2Fru-central3%2Fs3%2Faws4_request&X-Amz-Date=20260519T063956Z&X-Amz-Expires=300&X-Amz-SignedHeaders=host&X-Amz-Signature=b5c6d457facb26612523c38fea45d90504dd2263383383cad3fbf9bc9974077d "Telegram Channel logo \"[𝗢𝗡𝗟𝗜𝗡𝗘 𝗣𝗛𝗔𝗥𝗠𝗔™]\". Free Telegram Channel Analytics")
[𝗢𝗡𝗟𝗜𝗡𝗘 𝗣𝗛𝗔𝗥𝗠𝗔™]
➽ 𝗣𝗿𝗼𝗺𝗼𝘁𝗲 𝗼𝗻 ꧁᪣ 𝗢𝗡𝗟𝗜𝗡𝗘 𝗣𝗛𝗔𝗥𝗠𝗔™᪣ ꧂
ማስታወቂያ ለማሰራት @animax_brush ያናግሩን
1post :- 100 birr or by adding contacts
Every one is #HERE :- Ethiopian medicine importers,wholesalers Hospitals,doctors,pharmacists, Lab tech......
Channel statistics
Subscribers:
12.7K
APV
ERR
0.0
ER
—
СPM:
Posts per day:
4.0
Similar channels:
Health & Medicine
Statistics and analytics of the Telegram channel [𝗢𝗡𝗟𝗜𝗡𝗘 𝗣𝗛𝗔𝗥𝗠𝗔™]
12.7K
Subscribers*
+0
yesterday
-83
in the last week
-60
in the last month
lock
Views per post*
lock
in the first 24 hours
Temporarily missing data
—
ER*
—
Average reach (over 24hr)
—
Emoji Reaction Rate of promotional posts over 7 days
*Changes within 30 days
—
Total number of posts*
--
Completed orders on Telega.io
0
Repeat orders on Telega.io
2 years и 3 months
Channel age
—
men
—
women
[𝗢𝗡𝗟𝗜𝗡𝗘 𝗣𝗛𝗔𝗥𝗠𝗔™] — is a Telegram channel with an audience of 12.7K subscribers. Each post averages 0 views, аnd the engagement rate (ER) is %.
keyboard_double_arrow_left
shopping_cart
Channels:
0
Subscribers:
0
Views:
lock_outline
Clear the cart
Are you sure you want to clear the cart?
You will be able to add channels from the catalog to the cart again.
You will be able to add channels from the catalog to the cart again.
Комментарий